Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of magnesium sulfate on nausea and vomiting after cesarean section
IRCT20250526065901N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in postoperative nausea and vomiting (PONV), sponsored by Alborz University of Medical Sciences. Primary endpoints: postoperative nausea incidence and postoperative vomiting incidence. Started Jun 2025; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20250526065901N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250526065901N1.